Page 11 - CPG - Clinical Practice Guidelines - Management of Cancer Pain
P. 11

Management of Cancer Pain (Second Edition)
                  •  WHO  Guidelines  on the Pharmacological  Treatment of  Persisting
                    Pain in Children with Medical Illness 2012

                  A total of 23 main clinical  questions were developed  under different
                  sections. Members of the DG were assigned individual questions within
                  these sections. Refer to Appendix 2 for Clinical Questions. The DG
                  members met 24 times throughout the development of these guidelines.
                  All literature retrieved was appraised by at least two DG members using
                  the Critical Appraisal Skill Programme checklist, presented in evidence
                  tables and further discussed in each DG meeting. All statements and
                  recommendations formulated after that were agreed upon by both the
                  '* DQG WKH UHYLHZ FRPPLWWHH  5&   :KHUH HYLGHQFH ZDV LQVXI¿FLHQW
                  the recommendations were made by consensus of the DG and RC. Any
                  differences in opinion are resolved consensually. The CPG was mainly
                  EDVHG RQ WKH ¿QGLQJV RI V\VWHPDWLF UHYLHZV  PHWD DQDO\VHV DQG FOLQLFDO
                  trials, with local practices considered.
                  The literature  used in these guidelines  was graded  using  the US/
                  Canadian  Preventive Services Task Force Level of Evidence (2001)
                  while the recommendation grading was done using GRADE principles
                  (refer to the preceding page). The writing of the CPG follows strictly
                  the requirement of Appraisal of Guidelines for Research and Evaluation
                  (AGREE II).

                  On completion, the draft CPG was reviewed by external reviewers. It
                  ZDV DOVR SRVWHG RQ WKH 0R+ 0DOD\VLD RI¿FLDO ZHEVLWH IRU IHHGEDFN IURP
                  DQ\ LQWHUHVWHG SDUWLHV  7KH GUDIW ZDV ¿QDOO\ SUHVHQWHG WR WKH 7HFKQLFDO
                  Advisory Committee for CPG and, the Health Technology Assessment
                  (HTA) and CPG Council,  MoH Malaysia,  for review and approval.
                  Details on the CPG development by MaHTAS can be obtained from
                  the  Manual on Development and Implementation  of Evidence-
                  based Clinical Practice Guidelines published in 2015 (available at
                  https://www.moh.gov.my/moh/resources/CPG_MANUAL_MAHTAS.pdf).




















                                              v



          e-cpg kandungan-Cancer pain 12/6/24.indd   10                 09/08/2024   12:09 AM
   6   7   8   9   10   11   12   13   14   15   16